Embedded Files
We are pleased to announce 25 sites are open for enrollment for SPARX3.
We are pleased to announce 25 sites are open for enrollment for SPARX3.
1. University of Alabama at Birmingham2. University of Alberta3. Boston University4. University of California San Francisco (UCSF)5. University of Cincinnati6. Cleveland Clinic7. University of Colorado at Denver8. Columbia University Medical Center9. Emory University10. University of Florida11. Iowa State University12. University Hospitals/Kent State University13. Louisiana State University & LSU Health Science Center14, University of Michigan15. University of Minnesota16. Morehouse School of Medicine17. Northwestern University18. Ohio Health19. Oregon Health & Science University20. University of Pennsylvania 21. University of Pittsburgh22. Rush University23. UT Health San Antonio24. University of Utah and Intermountain Healthcare25. Washington University in St. Louis
Aerobic exercise is a vital treatment for people living with Parkinson’s disease. Although anti-parkinsonian medication helps alleviate Parkinson’s symptoms, it is not known to slow the rate of disease progression. Aerobic exercise is a treatment with the most compelling evidence for its potential to slow Parkinson's disease progression. While both moderate- and high-intensity aerobic exercise provides health benefits, it is currently unclear which intensity is more effective for people with Parkinson’s.
The SPARX3 (NCT04284436) study is the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s.
Research reported in this film-clip was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number U01NS113851. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Are you interested in becoming part of the SPARX3 research study?
We are actively recruiting participants. Learn more about how you can become a participant here.
Page updated
Google Sites
Report abuse